Versant Venture Management, LLC
Top Portfolio Positions
7 positions ·
$140,968,881 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
3,180,780 | $52,323,831 | 37.12% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
12,166,109 | $27,495,406 | 19.50% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
2,656,888 | $24,310,525 | 17.25% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
1,525,820 | $21,437,771 | 15.21% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
542,628 | $7,086,721 | 5.03% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
148,831 | $7,079,890 | 5.02% | |
| SKYE |
Skye Bioscience, Inc.
Healthcare
|
2,007,704 | $1,234,737 | 0.88% |
Portfolio Trend
25 quarters · across all stocks
Holdings in GLUE
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,323,831 | 3,180,780 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $68,720,532 | 4,382,687 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $41,888,152 | 5,652,922 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $25,494,678 | 5,652,922 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $26,229,558 | 5,652,922 | Shares | Other | 2025-05-07 | |
| 2024-12-31 | $39,231,278 | 5,652,922 | Shares | Other | 2025-02-12 | |
| No 13F history on record for this holder in this stock. | ||||||